How already-approved Genentech drug could attack common — and potentially deadly — food allergies

A 20-year-old allergic asthma drug from Genentech Inc. will get a date with regulators as a potential treatment for people accidental exposed to multiple foods that set off their allergies.
Click here to view original post

Advertisement — Advertise with Biotech Networks